2007 Drug Topics OTC Cough, Cold, and Flu survey

A new option for adults who have experienced stroke will now be available to further reduce future risk.

Findings from a meta-analysis of over 125 clinical trials led the agency to require a class-wide label change.

Gilead’s current lenacapavir patent is what makes Dr Reddy’s Laboratories’ formulation tentative.

The candidate vaccine’s next steps will be going through the FDA’s Biologics License Application process.

The Milken Institute released survey results alongside new data regarding the need for pharmacists in extending effective GLP-1 care.

Through the ACCESS program, Mark Ey, RPh, notes that pharmacies can now start billing for a variety of services they’ve already been providing.

The medication significantly increased risk of pregnancy loss when compared with macrolide antibiotics, amoxicillin, and topical clindamycin for acne.

In part 3, Rebold explores improving the ART formulary protocol through introducing pharmacist-led transition-of-care services.